APOE and Alzheimer disease: Brain CT or MRI is an integral part of the diagnostic pathway in patients with suspected AD dementia; however, other methods such as PET scans, APOE genotyping, and the analysis of the core AD CSF biomarkers are not routinely used in clinical settings [33–36].